We use cookies

Essential storage keeps the site working (sign-in, theme, this choice). We'd also like to load Google Analytics to understand, in aggregate, how the site is used — never your genetic data. See our Cookie Policy.

FAAH rs324420: Understanding the Pro129Thr Variant

rs324420
Stress Response
Limited evidenceGene: FAAH

The rs324420 variant is a common genetic change in the FAAH gene that results in a Pro129Thr amino acid substitution. This variant is associated with reduced enzyme activity and altered endocannabinoid signaling, which may influence stress reactivity and various behavioral traits.

What each genotype means

C/CLower attention

Typical FAAH enzyme activity

You carry two copies of the common C allele, which encodes typical levels of fatty acid amide hydrolase enzyme activity and standard baseline endocannabinoid signaling. Studies observe typical neural amygdala threat reactivity and conventional physiological responses during acute stress challenges. Current clinical research indicates that this genotype reflects standard baseline stress regulation rather than elevated resistance or vulnerability.

Carried by approximately 50% to 65% of individuals across European and American populations, and over 70% in many African and East Asian cohorts.

C/AModerate attention

Moderately reduced FAAH activity

You carry one copy of the A missense allele (historically designated C385A or Pro129Thr), which is associated with moderately reduced FAAH enzyme stability and moderately elevated circulating anandamide. Research links this carrier status to diminished amygdala reactivity to threat cues and potentially enhanced fear extinction, although findings on chronic stress resilience are mixed and gene-environment interactions have been observed. Evidence remains limited and observational, so this genotype should not be viewed as predictive of stress-related outcomes.

Carried by roughly 30% to 40% of people of European and admixed American ancestry, and is less common in East Asian populations.

A/AModerate attention

Significantly reduced FAAH activity

You carry two copies of the A variant allele, which cellular studies associate with an approximate 50% reduction in FAAH catalytic activity and notably higher endogenous anandamide concentrations. Neuroimaging and behavioral studies frequently link this genotype to blunted amygdala reactivity to fearful stimuli and potentially improved adaptation to acute psychological stressors. However, clinical evidence is preliminary and some studies report that early environmental adversity may alter these outcomes, meaning real-world effects on mood and stress vary considerably.

Found in approximately 4% to 9% of individuals of European ancestry, and in under 2% to 3% of individuals of East Asian or African ancestry.

What is the rs324420 Variant?

The rs324420 variant is a single nucleotide polymorphism (SNP) located within the FAAH gene on chromosome 1. Specifically, it involves a change from a cytosine (C) to an adenine (A) nucleotide. This genetic alteration leads to a missense mutation where the amino acid proline is replaced by threonine at position 129 of the FAAH protein (Pro129Thr). This structural change makes the FAAH enzyme more susceptible to degradation, which effectively lowers the amount of functional enzyme available in the body. Because this variant directly impacts the protein's stability and function, it is considered a functional polymorphism. Researchers study this SNP to understand how subtle changes in protein structure can lead to broader physiological differences in how individuals process signaling molecules within the endocannabinoid system.

The Role of the FAAH Gene

The FAAH gene provides instructions for creating the fatty acid amide hydrolase (FAAH) enzyme. This enzyme plays a critical role in the endocannabinoid system, a complex cell-signaling network that helps regulate various physiological processes, including mood, pain sensation, appetite, and stress response. FAAH is primarily responsible for breaking down anandamide, an endocannabinoid that acts as a neurotransmitter. By degrading anandamide, FAAH helps maintain the balance of these signaling molecules in the brain and body. When the FAAH enzyme is less active—as is the case with the A-allele of rs324420—the breakdown of anandamide is slowed. This can lead to higher levels of endocannabinoids, which may influence how the nervous system responds to external stimuli, including stress, pain, and reward-related cues.

Research Associations and Evidence

Scientific research has investigated the association between the rs324420 variant and various behavioral and physiological outcomes. Studies have linked the A-allele to differences in stress perception, subjective responses to substances like cocaine, and variations in alcohol consumption patterns. Additionally, some research has explored its potential role in lipid metabolism, showing associations with circulating levels of specific endocannabinoid-related lipids. However, it is important to note that the evidence for these associations is often limited or mixed. Many findings have not been consistently replicated across different populations, and some studies suggest that the effects may be ancestry-specific or dependent on environmental factors. Because the endocannabinoid system is highly complex, it is difficult to isolate the impact of a single genetic variant from other genetic and environmental influences.

Population Frequency

The frequency of the rs324420 variant varies across different global populations. The minor allele (A) is generally found at a frequency of approximately 0.05 to 0.20 depending on the ancestral group, though some studies report higher frequencies in specific cohorts. Because the variant is relatively common, a significant portion of the population carries at least one copy of the A-allele. Understanding these frequencies is essential for researchers to ensure that genetic studies are representative of diverse groups and to avoid drawing conclusions that may not apply broadly.

Interpreting Genetic Information

Genetic information regarding the rs324420 variant is primarily used in research settings to understand biological pathways. It is not a diagnostic tool for any medical condition, nor can it predict individual behavior or health outcomes with certainty. If you have received information about your genotype for this variant, it is important to view it as a small piece of a much larger biological puzzle. Because the associations with stress or substance use are based on statistical trends in groups rather than individual certainty, this information should not be used to make personal health decisions. If you have concerns about stress, mood, or substance use, please consult with a qualified healthcare professional who can provide personalized guidance based on your clinical history rather than genetic markers alone.

How common is this variant?

The minor allele frequency for rs324420 is approximately 0.05 globally, though it varies by ancestry. The A-allele is present in a significant minority of the population, making the CA and AA genotypes observable in most large-scale genetic studies.

Frequently asked questions

Is the FAAH rs324420 variant a cause of addiction?

No, this variant is not a direct cause of addiction. While some research has explored statistical associations between this SNP and substance use behaviors, genetics is only one of many complex factors that contribute to addiction risk.

Can I use this genetic information to change my diet or lifestyle?

There is no evidence-based recommendation to change your diet or lifestyle based on your rs324420 genotype. Always consult with a healthcare provider before making significant changes to your health regimen.

Does this variant affect how I respond to pain?

Some research suggests that the endocannabinoid system, which is influenced by FAAH, plays a role in pain modulation. However, the specific impact of the rs324420 variant on individual pain perception is not well-established or clinically actionable.

Should I be worried if I have the AA genotype?

No, the AA genotype is a common genetic variation and is not a medical diagnosis. It simply represents a difference in the stability of one specific enzyme, and it does not imply that you will develop any specific health condition.

Sources & further reading

Educational information only, last refreshed 10/27/2026. Not medical advice — these associations describe population statistics, not individual predictions.

Curious what your genotype is for rs324420?

Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.

Get my report — $29

Related variants in FAAH